September 22, 2022 Experience Development Bank of Japan program update and $600 million senior notes offering We advised DBJ on its global MTN program update and sustainability bond offering
September 22, 2022 Experience InnoCare Pharma RMB2.9 billion Shanghai IPO This is the largest A-share listing by an overseas-listed biotechnology company in 2022 so far
September 21, 2022 Experience Tencent Music Entertainment Group secondary listing We advised Tencent Music Entertainment Group on its secondary listing by way of introduction on the HKEX
September 19, 2022 Experience Interra Acquisition HK$1 billion IPO We advised the SPAC on its IPO and HKEX listing
September 15, 2022 Experience Mitsubishi HC Capital $500 million senior notes offering We advised Mitsubishi HC Capital on its senior notes offering
September 15, 2022 Experience Sumitomo Mitsui Trust Bank $1 billion senior notes offering We advised Sumitomo Mitsui Trust Bank on the update of its global MTN program and senior notes offering
September 14, 2022 Experience Norinchukin Bank $1 billion senior notes offering The senior notes are due 2027 and 2032
September 13, 2022 Experience Mizuho Financial Group $1.75 billion senior notes offering The senior callable fixed-to-fixed reset rate notes are due 2028 and 2033
September 1, 2022 Experience Biocytogen HK$549 million IPO We advised Biocytogen on its IPO and HKEX listing